{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:25:33Z","timestamp":1792301133287,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.resinv.2019.03.007","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T12:19:21Z","timestamp":1555935561000},"page":"295-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Possible pathogenic roles of nitric oxide in asthma"],"prefix":"10.1016","volume":"57","author":[{"given":"Kazuhiro","family":"Yatera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2019.03.007_bib1","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0092-8674(94)90266-6","article-title":"Nitric oxide synthases: roles, tolls, and controls","volume":"78","author":"Nathan","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.resinv.2019.03.007_bib2","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1474","article-title":"Inhalation of nitric oxide modulates adult human bronchial tone","volume":"148","author":"Hogman","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.resinv.2019.03.007_bib3","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.bbagen.2011.06.009","article-title":"Nitric oxide metabolism in asthma pathophysiology","volume":"1810","author":"Ghosh","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.resinv.2019.03.007_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1165\/ajrcmb.21.2.3574","article-title":"Cationic proteins inhibit L-arginine uptake in rat alveolar macrophages: implications for nitric oxide synthesis","volume":"21","author":"Hammerman","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.resinv.2019.03.007_bib5","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.4049\/jimmunol.164.11.5970","article-title":"Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis","volume":"164","author":"Guo","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.resinv.2019.03.007_bib6","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1365-2222.2008.02969.x","article-title":"IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells","volume":"38","author":"Chibana","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.resinv.2019.03.007_bib7","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1046\/j.1365-2745.2002.01445.x","article-title":"Prevalence of endothelial nitric oxide synthase gene polymorphisms in patients with atopic asthma","volume":"32","author":"Holla","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.resinv.2019.03.007_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1165\/ajrcmb.21.2.f158","article-title":"Nitric oxide in asthma. Pathogenic, therapeutic, or diagnostic?","volume":"21","author":"Sanders","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.resinv.2019.03.007_bib9","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1084\/jem.189.10.1621","article-title":"Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma","volume":"189","author":"De Sanctis","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.resinv.2019.03.007_bib10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4049\/jimmunol.162.1.445","article-title":"Inhibition of allergic airway inflammation in mice lacking nitric oxide synthase 2","volume":"162","author":"Xiong","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.resinv.2019.03.007_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1465-9921-7-58","article-title":"Overexpression of endothelial nitric oxide synthase suppresses features of allergic asthma in mice","volume":"7","author":"Ten Broeke","year":"2006","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2019.03.007_bib12","doi-asserted-by":"crossref","first-page":"1015e1023","DOI":"10.1016\/S0092-8674(00)81796-1","article-title":"Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase","volume":"87","author":"Son","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.resinv.2019.03.007_bib13","doi-asserted-by":"crossref","first-page":"H429e436","DOI":"10.1152\/ajpheart.00501.2001","article-title":"Neuronal NOS-dependent dilation to flow in coronary arteries of male eNOS-KO mice","volume":"282","author":"Huang","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.resinv.2019.03.007_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00408-015-9833-4","article-title":"Decreased bronchial eosinophilic inflammation and mucus hypersecretion in asthmatic mice lacking all nitric oxide synthase Isoforms","volume":"194","author":"Akata","year":"2016","journal-title":"Lung"},{"key":"10.1016\/j.resinv.2019.03.007_bib15","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1164\/ajrccm.162.4.9909037","article-title":"Exhaled nitric oxide production by nitric oxide synthase-deficient mice","volume":"162","author":"Steudel","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2019.03.007_bib16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1152\/japplphysiol.01389.2003","article-title":"Expression of nitric oxide synthase-2 in the lungs decreases airway resistance and responsiveness","volume":"97","author":"Hjoberg","year":"2004","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.resinv.2019.03.007_bib17","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0954-6111(98)90189-5","article-title":"Exhaled nitric oxide: relationship to clinicophysiological markers of asthma severity","volume":"92","author":"Al-Ali","year":"1998","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2019.03.007_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","article-title":"Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting \u03b22 agonist: a randomized double-blind placebo-controlled pivotal phase 2b dose-ranging trial","volume":"388","author":"Wenzel","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.resinv.2019.03.007_bib19","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","article-title":"Dupilumab in persistent asthma with elevated eosinophil levels","volume":"368","author":"Wenzel","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2019.03.007_bib20","doi-asserted-by":"crossref","first-page":"e0211790","DOI":"10.1371\/journal.pone.0211790","article-title":"A meta-analysis of anti-interleukin-13 monoclonal antibodies for uncontrolled asthma","volume":"14","author":"Li","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2019.03.007_bib21","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4049\/jimmunol.1500736","article-title":"Metabolomic endotype of asthma","volume":"195","author":"Comhair","year":"2015","journal-title":"J Immunol"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534518303101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534518303101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T22:42:53Z","timestamp":1694817773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534518303101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S2212534518303101"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2019.03.007","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Possible pathogenic roles of nitric oxide in asthma","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2019.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}